ADAR1 Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2M Sell
1,554,535
-26,908
-2% -$266K 0.7% 32
2026
Q1
$15.4M Buy
1,581,443
+123,679
+8% +$1.13M 0.9% 22
2025
Q4
$13.9M Sell
1,457,764
-11,334
-0.8% -$115K 1.02% 22
2025
Q3
$14.3M Sell
1,469,098
-1,905,911
-56% -$14.6M 1.35% 13
2025
Q2
$20.5M Buy
+3,375,009
New +$25.3M 3.14% 8
2024
Q3
Sell
-5,988
Closed -$124K 327
2024
Q2
$124K Hold
5,988
0.02% 161
2024
Q1
$148K Sell
5,988
-114
-2% -$3.39K 0.03% 133
2023
Q4
$222K Buy
+6,102
New +$235K 0.08% 82

Other funds holding PRTA

ADAR1 Capital Management's PRTA Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Prothena Corp (PRTA) stake by 1.7% in Q2 2026, selling an estimated $266K and leaving 1,554,535 shares worth $15.2M. The position accounts for 0.7% of the portfolio, ranked #32.

ADAR1 Capital Management first reported a position in PRTA in Q4 2023 and has held it in 8 quarters since. The position peaked at $20.5M in Q2 2025. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • ADAR1 Capital Management held 1,554,535 shares of Prothena Corp worth $15.2M as of Q2 2026.
  • ADAR1 Capital Management sold 26,908 Prothena Corp shares in Q2 2026, an estimated $266K.
  • Prothena Corp made up 0.7% of ADAR1 Capital Management's portfolio in Q2 2026, its #32 holding.
  • ADAR1 Capital Management first reported a position in Prothena Corp in Q4 2023 and has held it in 8 quarters since.
  • ADAR1 Capital Management's Prothena Corp position peaked at $20.5M in Q2 2025.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.